Analyst Blog

ASASS (ACROSS International Symposium on Advances in Separation Science) is an International Symposium dedicated to showcasing the latest and greatest achievements in the field of separation science and related techniques, bringing together the leading scientists and practitioners within Australia, with invited international experts of world renown.

ASASS will be taking place from November 30 to December 2 in Hobart, Tasmania.

To find out more details about ASASS 2016, please click here. You can also see here for registration information.

Congratulations to Editorial Board member Boris Mizaikoff and researchers at Ulm University for winning a second prize in the RSC Emerging Technologies Competition 2016.

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual innovation initiative, turning promising ideas into commercial reality. Now in its fourth year, the competition brings cutting edge science to the real world for the benefit of society.

Entrants were required to pitch their ideas to a panel of expert judges, in front of a live audience, at Chemistry Means Business on 15 June 2016.

Professor Mizaikoff and researchers at Ulm University, were awarded second prize in the Health & Wellbeing category for their advanced infrared breath diagnostic devices.

“Ulm University is using substrate-integrated hollow waveguides to facilitate the development of label-free miniaturised breath diagnostic devices, based on mid-infrared sensing technology. This allows quantitative determination of volatile organic biomarkers in exhaled breath within minute sample volumes, with high time resolution, and with inherent molecular selectivity at trace levels.”

You can read more about the winners of the competition here and also register your interest for next years competition.

Surface-enhanced Raman scattering (SERS) can help optimise radiotherapy treatment regimes for prostate cancer, UK scientists have shown.

Prostate cancer is the second most common cancer worldwide in men, and the fourth most common cancer overall. It is usually treated with radiotherapy, and doctors would like to tailor doses for individual patients. This would help maximise tumour cell destruction, while minimising damage to normal tissue.

To read the full article by Sarah Rogers, please visit Chemistry World.

Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors

Victoria L. Camus, Grant Stewart, William H. Nailon, Duncan B. McLarend and Colin J. Campbell
Analyst, 2016
DOI:  10.1039/C6AN01032F